Commonground
Senior Moderator
March 19, 2010
The Ministry of Health, Labor and Welfare of Japan reported that nearly 100 million doses of influenza virus A/H1N1 / worth about 112.6 billion yen 1.25 billion dollars / have not been used to combat the infection.
Office is negotiating with the British company GlaxoSmithKline and the Swiss firm Novartis rescinding supply. Contracts were signed in October last year on a wave of hype that it may be lack of preparation. Initially, the Japanese government anticipated that the need to vaccinate people twice. However, doctors later confirmed that immunity is sufficient to produce a single vaccination. By the end of January, about 18 million Japanese people vaccinated against the new flu. Ministry of Health, notes that the number of citizens who need the vaccine dramatically reduced.
Source: Ami-tass.ru
http://translate.googleusercontent....&twu=1&usg=ALkJrhjGwWWzTOwr8UOdxUd4M59h48GdSQ
The Ministry of Health, Labor and Welfare of Japan reported that nearly 100 million doses of influenza virus A/H1N1 / worth about 112.6 billion yen 1.25 billion dollars / have not been used to combat the infection.
Office is negotiating with the British company GlaxoSmithKline and the Swiss firm Novartis rescinding supply. Contracts were signed in October last year on a wave of hype that it may be lack of preparation. Initially, the Japanese government anticipated that the need to vaccinate people twice. However, doctors later confirmed that immunity is sufficient to produce a single vaccination. By the end of January, about 18 million Japanese people vaccinated against the new flu. Ministry of Health, notes that the number of citizens who need the vaccine dramatically reduced.
Source: Ami-tass.ru
http://translate.googleusercontent....&twu=1&usg=ALkJrhjGwWWzTOwr8UOdxUd4M59h48GdSQ